Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04965324
Other study ID # A+9283
Secondary ID ACTRN12612000632
Status Completed
Phase
First received
Last updated
Start date December 19, 2012
Est. completion date May 31, 2021

Study information

Verified date July 2021
Source Auckland City Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Anaesthetic depth and complications after major surgery: an international, randomised controlled trial - The BALANCED trial. In this large, international, randomised controlled trial that enrolled patients aged 60 years and over with significant comorbidity and at increased risk of complications after major surgery, we found no evidence that light general anaesthesia (bispectral index 50) was superior to deep general anaesthesia (bispectral index 35) in reducing 1-year mortality. The BALANCED long term follow up study will look at whether depth of anesthesia affects long term (beyond 1 year) survival. The primary hypothesis is that targetting BIS 50 will result in superior long term survival compared to targetting BIS 35. The two secondary hypotheses are that BIS titration to BIS 50 will 1. reduce local cancer recurrence or metastatic spread and consequently improve long-term survival 2. reduce postoperative delirium and associated cognitive impairment and consequently improve long-term survival Both these mechanisms would be expected to take longer to manifest as reduced survival than 1-year all-cause mortality primary outcome in the Balanced trial. Trials of cancer outcomes often use 5-year survival or similar timeframes to determine evidence of clinical benefit. A steeper cognitive trajectory due to intermediate outcomes such as delirium and cognitive impairment may take longer than 1 year to produce a clinically important difference in survival 30. The 10.6% relative risk reduction seen in the Balanced trial could translate to a statistically and clinically meaningful survival difference in this high-risk population. This population may have 5-year survival of ~80% translating to an absolute survival difference of ~2% potentially (if the ~10% RRR is maintained beyond 1 year). The alternative is that there is no long-term mortality difference which would provide continuing clinical guidance of the safety of current practice in patients who are not at high risk of delirium. This study could provide a rationale for trials in larger populations (such as the total Balanced trial population) or targeted subgroups such as cancer and delirium to provide further mechanistic insights. Long-term survival is an important patient-centred outcome. The mechanisms described above may manifest in longer-term outcomes providing a clear rationale for the current trial.


Recruitment information / eligibility

Status Completed
Enrollment 6644
Est. completion date May 31, 2021
Est. primary completion date December 12, 2017
Accepts healthy volunteers No
Gender All
Age group 60 Years and older
Eligibility Inclusion and exclusion criteria will be the same as the Balanced trial with participants limited to those sites described above. Survival data will be censored at date of accessing mortality database. Inclusion 1. Age over 60 years and over 2. ASA physical status 3 or 4 3. Surgery expected to last over 2 hours 4. Hospital length of stay expected to be 2 nights or more 5. General anaesthesia with or without major regional block 6. Able to monitor BIS throughout anaesthesia Exclusion 1. Unable to monitor BIS 2. Unable to consent 3. Surgery with 'wake up' test 4. Propofol infusion for part or all of maintenance of anaesthesia 5. Previous enrolment in Balanced study Exclusion The intention-to-treat (ITT) population is defined as all randomised participants who met the inclusion and exclusion criteria who had surgery. The per-protocol (PP) population is defined as all randomised participants in the study who meet all the inclusion/exclusion criteria for BALANCED with BIS group classified according to the actual median BIS value achieved irrespective of randomisation. Participants were allocated to the BIS=50 group if the achieved median BIS is between 45 and 55 inclusive, and to the BIS=35 group if the achieved median BIS is between 30 and 40 inclusive. Participants who are not within these ranges will be excluded from these analyses.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Anaesthesia Depth


Locations

Country Name City State
New Zealand Auckland City Hopsital Auckland

Sponsors (3)

Lead Sponsor Collaborator
Auckland City Hospital Australian and New Zealand College of Anaesthetists, Health Research Council, New Zealand

Country where clinical trial is conducted

New Zealand, 

Outcome

Type Measure Description Time frame Safety issue
Primary Survival Survival Between one year and eight years after randomization to the BALANCED Trial
See also
  Status Clinical Trial Phase
Completed NCT05062564 - Efficacy of LipiFlow in Patients Affected by Meibomian Gland Dysfunction in Reducing Post-cataract Surgery Dry Eye N/A
Completed NCT05346588 - THRIVE Feasibility Trial Phase 3
Completed NCT03930784 - A Real-world Study to Examine the Relationship Between Simple Physical Functioning Tests, Complications and Recovery Following Abdominal Surgery.
Not yet recruiting NCT04430972 - Immune Responsiveness and Outcome After Aortic Valve Surgery (Measure)
Recruiting NCT04887415 - Respiratory Strength Training in Cardiac Surgical Patients N/A
Recruiting NCT05254262 - Multicenter National Trial of Clinical Results of Surgical Elderly Patients
Recruiting NCT03561376 - Zinc Oxide Versus Petrolatum Following Skin Surgery Early Phase 1
Recruiting NCT05155878 - Prognostic Factors in Periampullary Tumors and Cysts
Recruiting NCT04967391 - Tumescence in HNC Skin Graft Reconstruction Phase 3
Terminated NCT03757455 - ERAS Protocol in Pancreaticoduodenectomy and Total Pancreatectomy N/A
Completed NCT03793816 - Tonsillectomy Using BiZactâ„¢ - a Randomized Side-controlled Clinical Trial N/A
Completed NCT03246165 - Predictive Factors and Complications of Delirium
Withdrawn NCT04090918 - Novel Methods for Characterizing Patients With Post-operative Atrial Fibrillation Secondary to Abdominal Surgery
Completed NCT05373238 - Same Day Discharge After Laparoscopic Hysterectomy
Completed NCT03938584 - The Effect of Vitamin C on Wound Healing In Mandibular Fracture Patients N/A
Not yet recruiting NCT05046925 - PACU for Postoperative Care After Major Thoracic and Abdominal Surgery
Not yet recruiting NCT04199208 - Does Prehabilitation Improve Outcome in Coloncancer Surgery? N/A
Completed NCT04550156 - Evaluation of the Introduction of a Colorectal Bundle in Left Sided Colorectal Resections N/A
Completed NCT04257344 - Use of Wearables for Early Detection of Complications After Major Acute Abdominal Surgery
Active, not recruiting NCT03721471 - Outcome of Very Old Patients Admitted for Elective Major Surgery, the Effect of Frailty